OBJECTIVES: A RCT assessed the effectiveness and costs of a home based video teleconsultation (HVT) setup to lower HbA1c in patients with type-2 diabetes against usual out-patient treatment on the hospital. The HVT equipment was delivered to the patients by the hospital. This analysis shows the potential incremental cost-effectiveness ratio (ICER) of using a HVT setup on six-months health care effects and costs. METHODS: The study effectiveness outcome was HbA1c level in %. The economic analysis was performed with a spreadsheet decision tree model with a Danish hospital payer’s direct cost perspective. Cost data were based on study measured time consumption pr. HVT, consultations at out-patient clinic, HVT-equipment, -subscription, -support costs, and hospital operating cost. Medicine costs weren’t included in the model. Model output included the cost of a 1 % point reduction of HbA1c, ICER, with a probabilistic sensitivity analysis (PSA). Two scenario analyses (SA) were made to capture costs of patient transport to the hospital and a future online platform, were patients can use their own computer/tablet to the video teleconsultations. RESULTS: A total of 39 patients (mean age 62, HbA1c 8.5%) were randomized to either usual care (UC) or HVT. At 6 months follow up the HVT group showed greater improvements from baseline HbA1c levels (-1.38% vs. -0.92%) and less costly (€199.9 vs. €208.2) against UC. The base case ICER showed a potential €–17.58 saving per reduction of 1% HbA1c point. A PSA confirmed the ICER trends despite data uncertainties. Both SA showed further savings (ICER: €-67.85 and €-69.13). Compliance was 100% for HVT group were several planned visits were cancelled in the UC group.CONCLUSIONS: The present analysis shows the potential benefits of a HVT setup on 6-months health care cost and effects against UC. Further savings could include cost associated with lost work days.